

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | amino sugar catabolic process (GO:0046348) | 4.63922821 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 4.61885181 |
| 3 | glycosphingolipid catabolic process (GO:0046479) | 4.34321061 |
| 4 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.01691964 |
| 5 | response to peptidoglycan (GO:0032494) | 3.92661650 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 3.91162788 |
| 7 | glycolipid catabolic process (GO:0019377) | 3.86786967 |
| 8 | regulation of mononuclear cell migration (GO:0071675) | 3.86216035 |
| 9 | response to thyroid hormone (GO:0097066) | 3.64482049 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 3.62016126 |
| 11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.60777679 |
| 12 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.58637334 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 3.57220640 |
| 14 | barbed-end actin filament capping (GO:0051016) | 3.51238854 |
| 15 | N-acetylneuraminate metabolic process (GO:0006054) | 3.49033342 |
| 16 | ceramide catabolic process (GO:0046514) | 3.46270122 |
| 17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28493543 |
| 18 | NIK/NF-kappaB signaling (GO:0038061) | 3.13649361 |
| 19 | amyloid precursor protein catabolic process (GO:0042987) | 3.09328984 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08252869 |
| 21 | regulation of cholesterol storage (GO:0010885) | 3.05560275 |
| 22 | keratan sulfate catabolic process (GO:0042340) | 3.03087694 |
| 23 | membrane lipid catabolic process (GO:0046466) | 3.02784249 |
| 24 | sphingolipid catabolic process (GO:0030149) | 2.99504049 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99486551 |
| 26 | regulation of antigen processing and presentation (GO:0002577) | 2.98099222 |
| 27 | virion attachment to host cell (GO:0019062) | 2.96640624 |
| 28 | adhesion of symbiont to host cell (GO:0044650) | 2.96640624 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 2.95164600 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92771919 |
| 31 | cellular response to type I interferon (GO:0071357) | 2.92694019 |
| 32 | type I interferon signaling pathway (GO:0060337) | 2.92694019 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89917812 |
| 34 | negative regulation of cell killing (GO:0031342) | 2.89917812 |
| 35 | response to type I interferon (GO:0034340) | 2.89833745 |
| 36 | T-helper 1 type immune response (GO:0042088) | 2.89098916 |
| 37 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.85978106 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84687957 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84687957 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 2.84687957 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84687957 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 2.84687957 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84687957 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84182772 |
| 45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80904786 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 2.78645929 |
| 47 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.78297163 |
| 48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.75586997 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75544945 |
| 50 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.73167244 |
| 51 | pinocytosis (GO:0006907) | 2.73099837 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71498579 |
| 53 | granulocyte activation (GO:0036230) | 2.70606448 |
| 54 | adhesion of symbiont to host (GO:0044406) | 2.69921238 |
| 55 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.68585880 |
| 56 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67874358 |
| 57 | phagosome maturation (GO:0090382) | 2.66579025 |
| 58 | lysosome organization (GO:0007040) | 2.66229749 |
| 59 | lytic vacuole organization (GO:0080171) | 2.66229749 |
| 60 | positive regulation of leukocyte degranulation (GO:0043302) | 2.65657281 |
| 61 | positive regulation of cholesterol efflux (GO:0010875) | 2.64257471 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 2.64030423 |
| 63 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62554089 |
| 64 | regulation of macrophage chemotaxis (GO:0010758) | 2.61311988 |
| 65 | mannose metabolic process (GO:0006013) | 2.61199103 |
| 66 | regulation of superoxide anion generation (GO:0032928) | 2.59649768 |
| 67 | monocyte chemotaxis (GO:0002548) | 2.59105376 |
| 68 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.57688475 |
| 69 | detection of other organism (GO:0098543) | 2.57364169 |
| 70 | regulation of leukocyte degranulation (GO:0043300) | 2.57245820 |
| 71 | apoptotic cell clearance (GO:0043277) | 2.56991788 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 2.56643029 |
| 73 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.56536190 |
| 74 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.54660974 |
| 75 | peptide catabolic process (GO:0043171) | 2.54464306 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.53250633 |
| 77 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.50116662 |
| 78 | negative regulation of innate immune response (GO:0045824) | 2.49818878 |
| 79 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.46814841 |
| 80 | Golgi transport vesicle coating (GO:0048200) | 2.46658020 |
| 81 | COPI coating of Golgi vesicle (GO:0048205) | 2.46658020 |
| 82 | hyaluronan catabolic process (GO:0030214) | 2.45229918 |
| 83 | detection of bacterium (GO:0016045) | 2.44713333 |
| 84 | low-density lipoprotein particle clearance (GO:0034383) | 2.44459096 |
| 85 | B cell mediated immunity (GO:0019724) | 2.44234841 |
| 86 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.40344997 |
| 87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.40233627 |
| 88 | protein localization to endosome (GO:0036010) | 2.39356440 |
| 89 | regulation of monocyte chemotaxis (GO:0090025) | 2.39269611 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.39170709 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 2.39170709 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.38892119 |
| 93 | detection of external biotic stimulus (GO:0098581) | 2.38802155 |
| 94 | positive regulation of interferon-alpha production (GO:0032727) | 2.38030548 |
| 95 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.36771675 |
| 96 | response to muramyl dipeptide (GO:0032495) | 2.36221319 |
| 97 | positive regulation of sterol transport (GO:0032373) | 2.35858038 |
| 98 | positive regulation of cholesterol transport (GO:0032376) | 2.35858038 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.35444091 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.35019143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.09894476 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.58730601 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19845660 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34599986 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33993859 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.33919048 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.32279373 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30723001 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30065304 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27178911 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25219773 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19976540 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14454531 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02848270 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97959493 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93351368 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.92011284 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91125793 |
| 19 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.89233474 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83853706 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.83301637 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78610495 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71782652 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71649398 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70237765 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70232585 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67407626 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66030351 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65056504 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.63630141 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63535077 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61937722 |
| 33 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.61668971 |
| 34 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.60723309 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60414619 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.55039269 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51733978 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50179001 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48611395 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48159414 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.48140405 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47958606 |
| 43 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44820932 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44091568 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43582844 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43370277 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42724751 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42130316 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41361878 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.40319267 |
| 51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39956177 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34972370 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34930303 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32764235 |
| 55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.32223468 |
| 56 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32087711 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30459915 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.29971072 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28392467 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28146281 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28111986 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.27814698 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26661726 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26395532 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25915408 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25184381 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.24945251 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24260782 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23285762 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22919039 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21742469 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20941362 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16411276 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15837553 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14361389 |
| 76 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14361097 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13755318 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13174522 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13065253 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10613611 |
| 81 | P68_20966046_ChIP-Seq_HELA_Human | 1.10340903 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09159505 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09159102 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08497268 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08353251 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07160305 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06696494 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06284300 |
| 89 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05610343 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05413408 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05380529 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04884455 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04437296 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04097836 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03189682 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03025272 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02519449 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01979145 |
| 99 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01873097 |
| 100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01006722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.31382703 |
| 2 | MP0009840_abnormal_foam_cell | 3.58137072 |
| 3 | MP0006082_CNS_inflammation | 3.32732762 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.13470548 |
| 5 | MP0003303_peritoneal_inflammation | 2.90226761 |
| 6 | MP0003436_decreased_susceptibility_to | 2.85599221 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.83578657 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.81850903 |
| 9 | MP0009785_altered_susceptibility_to | 2.45382042 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.42110212 |
| 11 | MP0005671_abnormal_response_to | 2.38268612 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.38097517 |
| 13 | MP0002419_abnormal_innate_immunity | 2.36370284 |
| 14 | MP0003724_increased_susceptibility_to | 2.32603063 |
| 15 | MP0000685_abnormal_immune_system | 2.30415337 |
| 16 | MP0000343_altered_response_to | 2.27744270 |
| 17 | MP0002254_reproductive_system_inflammat | 2.25308332 |
| 18 | MP0005025_abnormal_response_to | 2.21306379 |
| 19 | MP0000604_amyloidosis | 2.17083861 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.16013277 |
| 21 | MP0005387_immune_system_phenotype | 2.12781120 |
| 22 | MP0001790_abnormal_immune_system | 2.12781120 |
| 23 | MP0003075_altered_response_to | 2.08901823 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.99889515 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.87241999 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.84617839 |
| 27 | MP0002723_abnormal_immune_serum | 1.83468376 |
| 28 | MP0004510_myositis | 1.81281706 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.81224581 |
| 30 | MP0005451_abnormal_body_composition | 1.70742170 |
| 31 | MP0001853_heart_inflammation | 1.65935310 |
| 32 | MP0004947_skin_inflammation | 1.62820711 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.62456073 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.60614737 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.59362206 |
| 36 | MP0008469_abnormal_protein_level | 1.59337647 |
| 37 | MP0001800_abnormal_humoral_immune | 1.58995289 |
| 38 | MP0001819_abnormal_immune_cell | 1.58793056 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.55592054 |
| 40 | MP0000858_altered_metastatic_potential | 1.52135331 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.48017595 |
| 42 | MP0009764_decreased_sensitivity_to | 1.44528708 |
| 43 | MP0005310_abnormal_salivary_gland | 1.42186726 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.41669422 |
| 45 | MP0002405_respiratory_system_inflammati | 1.41534842 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.33787251 |
| 47 | MP0003329_amyloid_beta_deposits | 1.32227480 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.31967719 |
| 49 | MP0005365_abnormal_bile_salt | 1.29782357 |
| 50 | MP0009278_abnormal_bone_marrow | 1.28154344 |
| 51 | MP0001542_abnormal_bone_strength | 1.25479172 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.22805686 |
| 53 | MP0008260_abnormal_autophagy | 1.18997736 |
| 54 | MP0003186_abnormal_redox_activity | 1.18063445 |
| 55 | MP0005165_increased_susceptibility_to | 1.16440029 |
| 56 | MP0003448_altered_tumor_morphology | 1.12826072 |
| 57 | MP0000716_abnormal_immune_system | 1.07509172 |
| 58 | MP0003690_abnormal_glial_cell | 1.07291331 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.05750555 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.05750555 |
| 61 | MP0006054_spinal_hemorrhage | 1.03837550 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.03137714 |
| 63 | MP0005390_skeleton_phenotype | 0.97606494 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 0.96817777 |
| 65 | MP0005166_decreased_susceptibility_to | 0.94301341 |
| 66 | MP0004019_abnormal_vitamin_homeostasis | 0.94094071 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 0.93484082 |
| 68 | MP0003279_aneurysm | 0.92600696 |
| 69 | MP0003795_abnormal_bone_structure | 0.90299820 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 0.89519595 |
| 71 | MP0001849_ear_inflammation | 0.89380724 |
| 72 | MP0002429_abnormal_blood_cell | 0.88500300 |
| 73 | MP0009763_increased_sensitivity_to | 0.85689307 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.83386954 |
| 75 | MP0000689_abnormal_spleen_morphology | 0.82558238 |
| 76 | MP0001873_stomach_inflammation | 0.82140388 |
| 77 | MP0002398_abnormal_bone_marrow | 0.81930925 |
| 78 | MP0000920_abnormal_myelination | 0.81104850 |
| 79 | MP0003763_abnormal_thymus_physiology | 0.80658597 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79097193 |
| 81 | MP0000609_abnormal_liver_physiology | 0.76992324 |
| 82 | MP0003828_pulmonary_edema | 0.76270311 |
| 83 | MP0005164_abnormal_response_to | 0.76000469 |
| 84 | MP0004858_abnormal_nervous_system | 0.74418734 |
| 85 | MP0002722_abnormal_immune_system | 0.74293294 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.74013746 |
| 87 | MP0001764_abnormal_homeostasis | 0.72346376 |
| 88 | MP0005023_abnormal_wound_healing | 0.72037231 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 0.69596646 |
| 90 | MP0001851_eye_inflammation | 0.68497464 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.67397302 |
| 92 | MP0000371_diluted_coat_color | 0.67256418 |
| 93 | MP0002933_joint_inflammation | 0.67084492 |
| 94 | MP0003634_abnormal_glial_cell | 0.67008267 |
| 95 | MP0001663_abnormal_digestive_system | 0.66949195 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.64895940 |
| 97 | MP0001881_abnormal_mammary_gland | 0.64884827 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.64334372 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.63446766 |
| 100 | MP0002090_abnormal_vision | 0.63157847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 8.10217348 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.10217348 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.10217348 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 5.61182052 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.31234159 |
| 6 | Dysostosis multiplex (HP:0000943) | 5.15524214 |
| 7 | Loss of speech (HP:0002371) | 4.49440508 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.44565643 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.44013289 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.41364743 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.22807997 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.22807997 |
| 13 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.22807997 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.06706576 |
| 15 | Mucopolysacchariduria (HP:0008155) | 4.06706576 |
| 16 | Progressive neurologic deterioration (HP:0002344) | 3.44198525 |
| 17 | Axonal loss (HP:0003447) | 3.32199989 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.26712657 |
| 19 | Disinhibition (HP:0000734) | 3.18926170 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.10997663 |
| 21 | Vertebral compression fractures (HP:0002953) | 3.05066552 |
| 22 | Nuclear cataract (HP:0100018) | 3.01253932 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.99598592 |
| 24 | Mutism (HP:0002300) | 2.96670348 |
| 25 | Prolonged neonatal jaundice (HP:0006579) | 2.96343615 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 2.83322439 |
| 27 | Glomerulonephritis (HP:0000099) | 2.81369146 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.72323988 |
| 29 | Increased serum ferritin (HP:0003281) | 2.58536894 |
| 30 | Orchitis (HP:0100796) | 2.57141629 |
| 31 | Myositis (HP:0100614) | 2.50874994 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50412194 |
| 33 | J-shaped sella turcica (HP:0002680) | 2.49247542 |
| 34 | Purpura (HP:0000979) | 2.46369899 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.44009932 |
| 36 | Hepatosplenomegaly (HP:0001433) | 2.43116360 |
| 37 | Cardiomegaly (HP:0001640) | 2.40549910 |
| 38 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.37112403 |
| 39 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.35943188 |
| 40 | Amyloidosis (HP:0011034) | 2.33330578 |
| 41 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32199882 |
| 42 | Petechiae (HP:0000967) | 2.29256687 |
| 43 | Complement deficiency (HP:0004431) | 2.23216362 |
| 44 | Diminished motivation (HP:0000745) | 2.20074335 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.19317296 |
| 46 | Optic neuritis (HP:0100653) | 2.19317296 |
| 47 | Retinal atrophy (HP:0001105) | 2.17222050 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14983675 |
| 49 | Obstructive lung disease (HP:0006536) | 2.14983675 |
| 50 | Myocardial infarction (HP:0001658) | 2.13467254 |
| 51 | Apathy (HP:0000741) | 2.11916115 |
| 52 | Joint stiffness (HP:0001387) | 2.07335011 |
| 53 | Abnormality of complement system (HP:0005339) | 2.02268346 |
| 54 | Abnormality of iron homeostasis (HP:0011031) | 1.99365830 |
| 55 | Stomatitis (HP:0010280) | 1.97850716 |
| 56 | Upper motor neuron abnormality (HP:0002127) | 1.95182680 |
| 57 | Urticaria (HP:0001025) | 1.94192627 |
| 58 | Recurrent skin infections (HP:0001581) | 1.94008310 |
| 59 | Neuronal loss in central nervous system (HP:0002529) | 1.93801746 |
| 60 | Bone cyst (HP:0012062) | 1.93039237 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 1.92778159 |
| 62 | Increased CSF protein (HP:0002922) | 1.92537268 |
| 63 | Thoracic kyphosis (HP:0002942) | 1.89817046 |
| 64 | Increased IgM level (HP:0003496) | 1.89663972 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 1.89118032 |
| 66 | Pulmonary infiltrates (HP:0002113) | 1.88284983 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 1.88177798 |
| 68 | Hypokinesia (HP:0002375) | 1.87680098 |
| 69 | Bone pain (HP:0002653) | 1.87419320 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 1.86761065 |
| 71 | Hematochezia (HP:0002573) | 1.86640292 |
| 72 | Dementia (HP:0000726) | 1.86551094 |
| 73 | Pathologic fracture (HP:0002756) | 1.83739688 |
| 74 | Cervical subluxation (HP:0003308) | 1.83723177 |
| 75 | Neoplasm of head and neck (HP:0012288) | 1.78477714 |
| 76 | Esophageal neoplasm (HP:0100751) | 1.78477714 |
| 77 | Hypertensive crisis (HP:0100735) | 1.75622626 |
| 78 | Xanthomatosis (HP:0000991) | 1.74867021 |
| 79 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74028708 |
| 80 | Malnutrition (HP:0004395) | 1.74010330 |
| 81 | Nephritis (HP:0000123) | 1.73230977 |
| 82 | Restrictive lung disease (HP:0002091) | 1.72416832 |
| 83 | Ovoid vertebral bodies (HP:0003300) | 1.70649101 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.70405156 |
| 85 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.70195278 |
| 86 | Polyneuropathy (HP:0001271) | 1.68854409 |
| 87 | Rough bone trabeculation (HP:0100670) | 1.68614211 |
| 88 | Prostate neoplasm (HP:0100787) | 1.67620790 |
| 89 | Personality changes (HP:0000751) | 1.64475559 |
| 90 | Premature rupture of membranes (HP:0001788) | 1.64178491 |
| 91 | Recurrent fungal infections (HP:0002841) | 1.63373654 |
| 92 | Vasculitis (HP:0002633) | 1.62577934 |
| 93 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.61415470 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 1.60791490 |
| 95 | Hemoptysis (HP:0002105) | 1.60665470 |
| 96 | Albinism (HP:0001022) | 1.59895163 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.59338245 |
| 98 | Basal ganglia calcification (HP:0002135) | 1.58945354 |
| 99 | Premature loss of primary teeth (HP:0006323) | 1.57820575 |
| 100 | Abnormal trabecular bone morphology (HP:0100671) | 1.56234758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.09354902 |
| 2 | IRAK3 | 3.68669080 |
| 3 | ERN1 | 3.28413051 |
| 4 | MAP4K1 | 3.20316510 |
| 5 | TAOK3 | 3.19512290 |
| 6 | TXK | 2.95662025 |
| 7 | TESK2 | 2.81273523 |
| 8 | TBK1 | 2.62009628 |
| 9 | TESK1 | 2.58693942 |
| 10 | BCKDK | 2.54060964 |
| 11 | BLK | 2.13331794 |
| 12 | TYK2 | 1.94403622 |
| 13 | MAP3K14 | 1.94201798 |
| 14 | PIM2 | 1.93283339 |
| 15 | TRIB3 | 1.79876257 |
| 16 | PRPF4B | 1.77180702 |
| 17 | TGFBR2 | 1.75663327 |
| 18 | IKBKB | 1.72990838 |
| 19 | TAOK2 | 1.67998421 |
| 20 | MAP3K3 | 1.65170293 |
| 21 | IKBKE | 1.56893405 |
| 22 | ZAP70 | 1.56711707 |
| 23 | ARAF | 1.54769989 |
| 24 | GRK7 | 1.54410018 |
| 25 | MAP3K11 | 1.51532570 |
| 26 | ABL2 | 1.46278677 |
| 27 | MAP2K3 | 1.44837458 |
| 28 | LIMK1 | 1.44304107 |
| 29 | IRAK4 | 1.43980295 |
| 30 | SIK1 | 1.39237956 |
| 31 | MAPKAPK3 | 1.31542766 |
| 32 | DDR2 | 1.29246267 |
| 33 | PAK4 | 1.27334106 |
| 34 | JAK3 | 1.25960805 |
| 35 | CSK | 1.25126799 |
| 36 | EPHA2 | 1.18126566 |
| 37 | MATK | 1.13312169 |
| 38 | JAK1 | 1.09373256 |
| 39 | RIPK4 | 1.06175927 |
| 40 | RIPK1 | 1.01746354 |
| 41 | MOS | 0.99801730 |
| 42 | CSF1R | 0.97811876 |
| 43 | TAOK1 | 0.93031844 |
| 44 | SMG1 | 0.92933635 |
| 45 | MAP3K13 | 0.90432455 |
| 46 | PDK2 | 0.86849283 |
| 47 | GRK6 | 0.83509944 |
| 48 | EPHB1 | 0.83189071 |
| 49 | MAP2K2 | 0.82773845 |
| 50 | TNK2 | 0.81258520 |
| 51 | MAP3K1 | 0.80826119 |
| 52 | CDC42BPA | 0.80565527 |
| 53 | PRKD2 | 0.78176245 |
| 54 | FGR | 0.76378146 |
| 55 | LYN | 0.75610156 |
| 56 | CHUK | 0.71902491 |
| 57 | MAP2K6 | 0.71700370 |
| 58 | KIT | 0.69776864 |
| 59 | ADRBK2 | 0.68980425 |
| 60 | SYK | 0.64795609 |
| 61 | FES | 0.64287906 |
| 62 | PDPK1 | 0.62577178 |
| 63 | LCK | 0.61691836 |
| 64 | HCK | 0.61244966 |
| 65 | NEK9 | 0.60285118 |
| 66 | IRAK1 | 0.60012555 |
| 67 | TLK1 | 0.58761118 |
| 68 | CAMKK2 | 0.58220521 |
| 69 | IRAK2 | 0.58161680 |
| 70 | MAPKAPK2 | 0.57545148 |
| 71 | STK10 | 0.56068463 |
| 72 | CAMK1D | 0.55517567 |
| 73 | RPS6KA2 | 0.54446973 |
| 74 | PTK6 | 0.49901576 |
| 75 | JAK2 | 0.49317449 |
| 76 | LRRK2 | 0.48693952 |
| 77 | HIPK2 | 0.48491334 |
| 78 | MARK3 | 0.48239463 |
| 79 | STK16 | 0.48193892 |
| 80 | BTK | 0.47350436 |
| 81 | KDR | 0.45416182 |
| 82 | ICK | 0.41298683 |
| 83 | DAPK3 | 0.41013170 |
| 84 | PKN2 | 0.40781955 |
| 85 | EPHB2 | 0.39408994 |
| 86 | LMTK2 | 0.39382254 |
| 87 | PRKG2 | 0.38901204 |
| 88 | RPS6KL1 | 0.37991160 |
| 89 | RPS6KC1 | 0.37991160 |
| 90 | FGFR4 | 0.36684258 |
| 91 | VRK2 | 0.34951977 |
| 92 | BMX | 0.34558468 |
| 93 | PRKCI | 0.34053268 |
| 94 | ITK | 0.33705741 |
| 95 | BRAF | 0.32158007 |
| 96 | MAP3K8 | 0.31816154 |
| 97 | BMPR2 | 0.29871043 |
| 98 | RPS6KA6 | 0.29546091 |
| 99 | MAPK7 | 0.29531234 |
| 100 | PIM1 | 0.28719446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 5.22219333 |
| 2 | * Lysosome_Homo sapiens_hsa04142 | 3.96969991 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.67679562 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.94484245 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.55865147 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.33863142 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.23661389 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22150136 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17568240 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13332755 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.09653211 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02090298 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99197963 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88735594 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81737266 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.78666129 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.71922774 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.70134382 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65518315 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.63802017 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63465446 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62705974 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.61374686 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.59469275 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54133937 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51566123 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.51300194 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43104228 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36533223 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32795849 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25742466 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21940114 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19969676 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.15194379 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.14219101 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13921950 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.10020428 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09613265 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09122752 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05637514 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05493321 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02285009 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00739233 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99170506 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.99003948 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95837138 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.92374481 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88920740 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88755790 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85123697 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85076173 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83913031 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 0.83205514 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.82990465 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82840695 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82354557 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.78734774 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77209725 |
| 59 | Measles_Homo sapiens_hsa05162 | 0.76162272 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.75200849 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72475694 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64238843 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60384381 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56877858 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55090970 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52039146 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.50328101 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49733863 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.49557493 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49351808 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47329323 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42679348 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42263084 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41182278 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40781342 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40284229 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.39971476 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39368502 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39117184 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38596443 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37766529 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37307110 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36403994 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36274674 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35338839 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34825815 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33019593 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32307897 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31767229 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30630011 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26500503 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26016830 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24339937 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22657078 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21339850 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21211450 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20233298 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19650663 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19072739 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.17749812 |

